Angeles Wealth Management LLC Has $243,000 Stake in HCA Healthcare, Inc. (NYSE:HCA)

Angeles Wealth Management LLC boosted its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 7.0% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 808 shares of the company’s stock after purchasing an additional 53 shares during the period. Angeles Wealth Management LLC’s holdings in HCA Healthcare were worth $243,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of the stock. FMR LLC increased its holdings in shares of HCA Healthcare by 322.3% during the 3rd quarter. FMR LLC now owns 3,141,769 shares of the company’s stock worth $1,276,909,000 after purchasing an additional 2,397,883 shares during the period. Meritage Group LP bought a new stake in shares of HCA Healthcare in the 3rd quarter worth approximately $150,548,000. Canoe Financial LP raised its stake in shares of HCA Healthcare by 226,952.9% in the fourth quarter. Canoe Financial LP now owns 231,594 shares of the company’s stock valued at $69,513,000 after purchasing an additional 231,492 shares in the last quarter. Holocene Advisors LP increased its holdings in HCA Healthcare by 210.6% in the 3rd quarter. Holocene Advisors LP now owns 306,796 shares of the company’s stock valued at $124,691,000 after buying an additional 208,015 shares during the period. Finally, Nordea Investment Management AB increased its stake in HCA Healthcare by 29.7% in the fourth quarter. Nordea Investment Management AB now owns 843,764 shares of the company’s stock valued at $253,020,000 after acquiring an additional 193,075 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Buying and Selling at HCA Healthcare

In related news, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the transaction, the insider now directly owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. This represents a 29.76 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Phillip G. Billington sold 3,897 shares of the stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the sale, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.60% of the company’s stock.

Wall Street Analysts Forecast Growth

HCA has been the topic of several analyst reports. Raymond James lowered HCA Healthcare from an “outperform” rating to a “market perform” rating in a research note on Friday, November 22nd. Royal Bank of Canada lowered their target price on shares of HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating on the stock in a report on Monday, January 27th. TD Cowen decreased their price objective on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a research note on Monday, October 28th. Cantor Fitzgerald restated an “overweight” rating and set a $405.00 price target on shares of HCA Healthcare in a research report on Monday, January 27th. Finally, Bank of America decreased their target price on HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and an average price target of $385.67.

HCA Healthcare Stock Down 1.2 %

NYSE:HCA opened at $318.28 on Tuesday. The stock’s fifty day simple moving average is $313.75 and its 200-day simple moving average is $353.51. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14. The firm has a market capitalization of $80.62 billion, a P/E ratio of 14.49, a P/E/G ratio of 1.11 and a beta of 1.64. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period last year, the business posted $5.90 earnings per share. Equities research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be issued a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.90%. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend is Monday, March 17th. HCA Healthcare’s dividend payout ratio (DPR) is presently 12.02%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.